1,3-DIHYDRO-6-(SULFOOXY)-1-(2-(4-(3-(TRIFLUOROMETHYL)PHENYL)-1-PIPERAZINYL)ETHYL)-2H-BENZIMIDAZOL-2-ONE
UNII LC6T8F3LPW
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3-dihydro-6-(sulfooxy)-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2h-benzimidazol-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LC6T8F3LPW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1034706-39-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H21F3N4O5S NKNIFHAZIBPTPO-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3-dihydro-6-(sulfooxy)-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2h-benzimidazol-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.